GLOBAL IS LOCAL: OPPORTUNITIES AND CHALLENGES FOR TB ELIMINATION IN NEW YORK CITY

Similar documents
TB INTENSIVE WORKSHOP

November 14 15, :00am 4:00 pm. 225 Warren Street Newark, NJ

INFECTIOUS DISEASE MEDICINE FOR PRIMARY CARE. Napa Valley/Sonoma, California The Fairmont Sonoma Mission Inn & Spa October 2 4, 2015

Twelfth Annual Innovations and Trends in Cardiovascular Care Symposium:

Who Should Attend. Continuing Medical Education. Program Description. Learning Objectives. Glacier Canyon Lodge at The Wilderness Resort

INFECTIOUS DISEASE MEDICINE FOR PRIMARY CARE

Patient Safety Professional Program: Pre-work

Speaker Biographies Arjun Srinivasan, MD (CAPT, USPHS) Benjamin Chan, MD, MPH, Michael Calderwood, MD, MPH, FIDSA,

Online Activity 1 hour May 25, 2015 May 24, 2016

PROGRAM SYLLABUS. Jointly provided by Potomac Center for Medical Education and Rockpointe

CONVERSATIONS PRIMARY CARE

Validation of Education Activity Content. All departments developing and presenting continuing education programs certified for credit by LVHN.

Your role in the CME Activity: Presenter Author Planning Committee Moderator Program Director. Title of CME Activity: Activity Date:

emedcert Internet CME Requirements

CLINICAL ENDOCRINOLOGY FOR PRIMARY CARE

Ethics of Tuberculosis Prevention, Care and Control

Reprinted from FDA s website by

Drug User Health: Promoting Health and Reducing Harm in Medical Settings

ALLEGHENY GENERAL HOSPITAL Pittsburgh, Pennsylvania

The National Parkinson Foundation s Allied Team Training for Parkinson s (ATTP) Miami, Florida May 17-20, 2017

9:30 am Registration. Learner Objectives:

Quality in HIV Care: Guaranteeing Good Outcomes for Your HIV Patients. 8th Annual HIV Symposium

Satellite Broadcast. VA/DoD Clinical Practice Guideline for the Management of Chronic Kidney Disease in Primary Care. FOR ALL DoD and VA: DATE:

36 th Annual INFECTIOUS DISEASES CONFERENCE February 9-10, 2018

66 th Annual TUBERCULOSIS/RESPIRATORY DISEASE INSTITUTE. September 26-27, 2017 Raleigh Marriott Crabtree Valley 4500 Marriott Drive Raleigh, NC 27612

Estimated time to complete activity: 1.5 hours for medical professionals, 3 hours for non medical professionals

21st Annual Practical Review for the Clinician: Pediatric Allergy, Immunology and Infectious Diseases

Virginia Hospital & Healthcare Association 2018 Annual Meeting

National Disparities LAN Event Managing the Opioid Crisis: Perspectives from Rural Communities. Wednesday, March 14, :00 4:30 PM ET

pediatric gastroenterology

Pediatric Trauma Symposium

SECTION PROPOSAL FOR EDUCATION ACTIVITY:

Enhancing Person-Centered Care through Advance Care Planning

Current Topics in Pediatric Hematology and Oncology: A Guide for Pediatric Primary Care Providers

Cultivating A Culture of Safety in Healthcare

Campaign for Meds Management (CMM) April 26, 2016

Infectious Diseases Spring Symposium 2018

Current Topics in Pediatric and. Adolescent Gynecology

Registration Hours Monday, March 21: 4:00pm 6:00pm Tuesday, March 22: 7:00am 5:30pm Wednesday, March 23: 7:00am 12:00pm

Department of Veterans Affairs Employee Education System

Culturally Responsive. Friday. Health Care in Iowa THE UNIVERSITY OF IOWA PRESENTS

Culturally Responsive. Friday. Health Care in Iowa THE UNIVERSITY OF IOWA PRESENTS

OFFICE ORTHOPEDICS FOR PRIMARY CARE

CONVERSATIONS PRIMARY CARE

ACCME Data Request Form 792_ Page 1 of 8

BATTLING BIAS OCTOBER 11-13, 2017 BREAKING DOWN BARRIERS REGISTRATION NOW OPEN ANNUAL PATIENT SAFETY CONFERENCE. Jointly provided by

2017 Annual Symposium Improving Practice

Please scroll through and complete the entire form! Your application will not be accepted if all areas highlighted in yellow are not complete.

9th Annual Yale Pediatric Update

Assessment and Treatment of Tobacco Dependence in Cancer Care

Infectious Diseases in Adults

Perspectives in Pediatrics. Friday, October 18, Bryn Mawr Hospital Bryn Mawr, PA

FRIDAY, FEBRUARY 26, :15 A.M. TO 3:15 P.M.

Cultivating A Culture of Safety in Healthcare A National Patient Safety Conference. October 12-14, Asheville, North Carolina

Preconception Care Conference

Management of Colon and Rectal Diseases

Thursday, April 26, :00 8:00PM

Healthcare Access for Persons with Disabilities

FRIDAY, FEBRUARY 24, :15 A.M. TO 3:15 P.M.

Opioid Epidemic... A Community Crisis

Caring for Post Traumatic Stress in Primary Care Co-sponsored by CAMC Health Education and Research Institute

Infectious Diseases in Primary Care

Friday, May 19, TH Annual Sport-Related Concussion & Spine Injury Conference

EMERGENCY MEDICINE FOR PRIMARY CARE. Walt Disney World Resort, Florida Disney s Contemporary Resort March 8 10, 2019

JOIN US 2017 BRUCE LUCAS HEPATOLOGY AND LIVER TRANSPLANT SYMPOSIUM. Friday, Oct. 13, 2017

Being Resilient and Renewing Your Purpose in Healthcare

ANCC Accreditation Self-Study Criteria for Approved Providers

TUESDAY, APRIL 24, 2018 UPDATE ON: CHRONIC KIDNEY DISEASE

Infectious Diseases in Primary Care

The Indiana-ACC 20 th Annual Meeting

FIRST STEPS ADVANCE CARE PLANNING (ACP) September 11 13, 2018 La Crosse, Wisconsin

2017 Shock Symposium The Latest in Resuscitation and Critical Care. Conference Agenda & Registration Information

Best of San Antonio Breast Cancer Symposium

Basic Life Support + First Aid for Healthcare Providers 2016 Course

COMMUNITY CARE 20TH ANNIVERSARY

Directed by Mark B. Taylor, MD Gateway Aesthetic Institute and Laser Center Salt Lake City, Utah

Essentials of Primary Care: A Core Curriculum for Ambulatory Practice

15th Annual. Mid-Atlantic Interprofessional Leadership Conference. Friday, October 19, a.m. - 3 p.m.

Marianne Henry PHASE Practicum Presentation Johns Hopkins Bloomberg School of Public Health May 12, 2017

Western Slope SIM/TCPi Spring Collaborative Learning Session

1 st Annual Women s Health Update

Advances in Cardiovascular Care

2017 ACOEM APPLICATION FOR JOINT PROVIDERSHIP FOR CONTINUING EDUCATIONAL ACTIVITIES

The 2 nd Annual Quality in Clinical Research Conference wp.vcu.edu/qualitycr. April 28, 2017

San Francisco General Hospital INFECTION CONTROL

Dear Prospective Presenter:

The Institute for the Advancement of Human Behavior

A Data-Driven Approach to Improving Clinical and Economic Outcomes in Multiple Sclerosis

2018 HPTN Annual Meeting May 2018 Washington, DC

Symposium on Integrative Health: Advances in Research and Evidence-based Practice

Live Conference Activity* GUIDELINES (Revised October 2012)

April 13-14, th Annual Pediatric Neurology Symposium

NAMI Illinois 2010 Annual Conference

Practical Management of Acute Stroke

PHARMACOLOGY An Evidence-Based Practice Conference for Advanced Practice Clinicians

Annual Pediatric Update for the Practicing Physician

STROKE UPDATE 2015 XIX. Friday, September 18, 2015 XIX. Friday, September 18, Location: Westin Convention Center Hotel

Symposium. Cardiovascular Medicine. Friday, June 20, 2014 UNIVERSITY OF IOWA DIVISION OF DUCATION ONTINUING EDICAL

Inaugural Three Rivers Antimicrobial Stewardship Symposium

Infectious Diseases in Clinical Practice:

Transcription:

GLOBAL IS LOCAL: OPPORTUNITIES AND CHALLENGES FOR TB ELIMINATION IN NEW YORK CITY MARCH 21, 2016 CME/CE CERTIFIED ACTIVITY Course Location Bard Hall, Mailman School of Public Health 722 W 168 th Street New York, NY 10032 101 Jointly Provided By Global Tuberculosis Institute at Rutgers, The State University of New Jersey, Mailman School of Public Health at New York City Department of Health and Mental Hygiene Bureau of Tuberculosis Control and the Center for Continuing & Outreach Education at Rutgers Biomedical Health Sciences The Global Tuberculosis Institute at Rutgers is the tuberculosis Regional Training and Medical Consultation Center for the northeast United States This activity is supported in part by an educational grant from the Centers for Disease Control and Prevention, Division of Tuberculosis Elimination WHY COURSE IS NEEDED Management of TB requires a multidisciplinary approach which relies on knowledge of local epidemiology, populations at risk and successful interventions. This conference will provide updates in management of TB and prevention and management practices. It will also promote networking among colleagues, resource sharing and collaborations with partnering agencies. COURSE DESCRIPTION & OVERALL GOAL In commemoration of World TB Day, this conference will address TB prevention and control efforts in New York City to highlight progress in the fight against TB. Topics will include a review of local and global epidemiology, outbreak strategies, approaches for patient-centered TB care, dealing with challenges and opportunities for strengthening community partnerships. Question and answer sessions and panel discussions are included to enhance interaction and shared experiences. COURSE REQUIREMENTS In order to meet the learning objectives and receive continuing education credits, participants are required to attend the entire conference and complete an evaluation. A post-course follow up evaluation will be sent to participants within 1 month of the conference. A CE credit letter will be mailed to you in approximately 4-6 weeks.

WHO SHOULD ATTEND This conference is open to physicians, nurses, epidemiologists, researchers and students, as well as other health care workers who manage patients at risk for or diagnosed with TB infection or disease. OBJECTIVES Upon completion of this workshop, participants should be better able to: Define local and global epidemiological trends in tuberculosis to make informed decisions about outreach interventions and allocation of resources Apply the World Health Organization s 2015 End TB Strategy to diagnose and treat patients at risk for TB infection and disease Explain strategies for managing tuberculosis outbreaks through collaboration with stakeholders and community partners Apply patient-centered care approaches for the diagnosis, treatment and management of routine and complex cases Describe the challenges of managing tuberculosis in both clinical and academic settings FACULTY LIST Joseph Burzynski, MD, MPH Assistant Commissioner, Bureau of TB Control New York City Department of Health and Mental Hygiene E. Jane Carter, MD Associate Professor of Medicine and Director of Brown Kenya Program Brown University Warren Alpert Medical School Luke Davis, MD Associate Professor of Epidemiology Yale University School of Public Health Wafaa El-Sadr, MD, M PH Professor of Epidemiology; Professor of Medicine Mike Frick, MSc TB/HIV Project Officer Treatment Action Group Gerald H. Friedland, MD Professor of Medicine and Epidemiology Yale University Yael Hirsch-Moverman, PhD, MPH Assistant Professor William R. Jacobs, Jr., PhD Professor of Genetics, Microbiology & Immunology Albert Einstein College of Medicine Marian Loveday, MPhil, PhD

Senior Scientist South African Medical Research Council Nesri Padayatchi, MSc Deputy Director Centre for the AIDS Programme of Research in South Africa (CAPRISA) Neil Schluger, MD Chief, Division of Pulmonary, Allergy & Critical Care Medicine; Professor of Medicine, Epidemiology & Environmental Sciences Jeanne Sullivan Meissner, MPH Public Health Epidemiologist, Bureau of TB Control New York City Department of Health and Mental Hygiene Jennifer Zelnik, ScD, MSW Associate Professor and Social Policy Chair Touro College Graduate School of Social Work Centers for Disease Control and Prevention Jeff Spitz Public Health Associate PLANNING COMMITTEE -Mailman School of Public Health Barbara Aaron, BA Administrative Director Global Tuberculosis Institute Jennifer K. Campbell, MPH, CHES Training & Consultation Specialist Anita Khilall, MPH Director of Education & Training New York City Department of Health & Mental Hygiene Martha Alexander, MHS-Director of Training Elvy Barroso, MD, MSc, MSN, RN-Professional Development Coordinator Joseph Burzynski, MD, MPH - Assistant Commissioner Diana Nilsen, MD- Director of Medical Affairs Shaila Rao, EdD, MPH-Director of Outreach AGENDA Monday, March 21, 2016 8:30 am Registration 9:00 am Welcome & Overview 9:30 am The Global Tuberculosis Epidemic 2015-Jane Carter, MD 10:00 am The State of Tuberculosis in New York City 2015-Joseph Burzynski, MD, MPH 10:45 am Break 11:00 am Engaging the Patient and Community in TB Prevention: Learning from Drug Resistant TB/HIV Outbreaks in New York and South Africa-A Panel Discussion Wafaa El-Sadr, MD, MPH; Gerald H. Friedland, MD; Nesri Padayatchi, MSc; moderated by Jennifer Zelnick, MSW, ScD 12:00pm Lunch 1:15 pm Community-based Approaches to Tuberculosis Outbreak Response in New York City-Jeanne Sullivan Meisner, MPH 2:00 pm Patient Centered Care in TB: Setting the Agenda-A Panel Discussion-Mike Frick, MSc, Marian Loveday, MPhil, PhD, Luke Davis, MD; moderated by Yael Hirsch-Moverman, PhD, MPH

3:00 pm Scientific Challenges and Implications for Mycobacterial Persistence for TB Prevention-William R. Jacobs, Jr., PhD 3:30 pm Controversies in Global TB: Implications for TB Elimination in New York City-Neil Schluger, MD 4:00 pm Adjourn CONTINUING EDUCATION INFORMATION This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Rutgers, The State University of New Jersey, -Mailman School of Public Health and the New York City Department of Health and Mental Hygiene. Rutgers, The State University of New Jersey designates this live activity for a maximum of 5.5 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Rutgers, The State University of New Jersey, Center for Continuing and Outreach Education is an approved provider of continuing nursing education by the New Jersey State Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission On Accreditation. Provider Number P173-5/31/2016. This activity is awarded 5.5 contact hours (60 minute CH). Nurses should only claim those contact hours actually spent participating in the activity. PEER REVIEW STATEMENT In order to help ensure content objectivity, independence, and fair balance, and to ensure that the content is aligned with the interest of the public, CCOE has resolved all potential and real conflicts of interest through content review by non-conflicted, qualified reviewers. This activity has been peer reviewed for relevance, accuracy of content and balance of presentation by Jennifer K. Campbell, MPH, CHES and Arpita Jindani, MSW, MA. DISCLOSURE DISCLAIMER In accordance with the disclosure policies of Rutgers and to conform with ACCME and FDA guidelines, individuals in a position to control the content of this educational activity are required to disclose to the activity participants: 1) the existence of any relevant financial relationship with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients, with the exemption of non-profit or government organizations and non-health care related companies, within the past 12 months; and 2) the identification of a commercial product/device that is unlabeled for use or an investigational use of a product/device not yet approved. Financial Disclosure The following faculty and planning committee members have stated that they have no relevant financial relationships to disclose: Barbara Aaron, BA Martha Alexander, MHS Elvy Barroso, MD, MSc, MSN, RN Joseph Burzynski, MD, MPH Jennifer K. Campbell, MPH, CHES E. Jane Carter, MD Luke Davis, MD Wafaa El-Sadr, MD, MPH William R. Jacobs, Jr., PhD Anita Khilall, MPH Marian Loveday, MPhil, PhD Diana Nilsen, MD Nesri Padayatchi, MSc Shaila Rao, EdD, MPH Neil Schluger, MD

Mike Frick, MSc Gerald H. Friedland, MD Yael Hirsch-Moverman, PhD, MPH Jeff Spitz Jeanne Sullivan Meissner, MPH Jennifer Zelnick, ScD, MSW CCOE Staff Elizabeth Ward, MSJ, Executive Director has no relevant financial relationships to disclose. Off-Label/Investigational Use Disclosure This activity contains no information of commercial products/devices that are unlabeled for use or investigations uses of products not yet approved. CONTENT DISCLAIMER The views expressed in this activity are those of the faculty. It should not be inferred or assumed that they are expressing the views of any manufacturer of pharmaceuticals or devices, or Rutgers. It should be noted that the recommendations made herein with regard to the use of therapeutic agents, varying disease states, and assessments of risk, are based upon a combination of clinical trials, current guidelines, and the clinical practice experience of the participating presenters. The drug selection and dosage information presented in this activity are believed to be accurate. However, participants are urged to consult all available data or procedures before using them in clinical practice. Rutgers reserves the right to modify the activity content and faculty if necessary. COPYRIGHT Copyright 2015 Rutgers, The State University of New Jersey. All rights reserved including translation into other languages. No part of this activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording, or any information storage and retrieval systems, without permission in writing from Rutgers. Please direct continuing education related questions to CCOE at 973-972-4267 or email ccoe@ca.rutgers.edu. Please direct content or course related questions to Jennifer K. Campbell at 973-972-1261 or email jennifer.k.campbell@rutgers.edu.